This strategy has proven effective, as Ccm1+/−Msh2−/−, Ccm1+/−Trp53−/−, and Ccm2+/−Trp53−/− mice develop CCM lesions by 4 to 5 months of age [86,87,88]. The gene discussed is KRIT1; the disease is cerebral cavernous malformation.